Goldman Sachs reiterated a Conviction Buy on Amgen (NASDAQ: AMGN) with a price target of $145. Analyst Terence Flynn expects ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE